Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1200/JCO.24.00144
dc.identifier.other
WOS:001293663100009
dc.description.volume
dc.description.issue
Publisher
LIPPINCOTT WILLIAMS \& WILKINS
DOI
10.1200/JCO.24.00144